Asian Paints shuts down chemicals plant in Gujarat

19 Nov 2008

1

Asian Paints, the country's largest manufacturer of paints, today announced a temporary closure of its chemicals plant engaged in the manufacture of phthalic anhydride (PAN) at Ankleshwar.

Asian Paints said it was forced to close the plant manufacturing phthalic anhydride, which is used in the manufacture of paints, due to pressure from cheap imports.

Thirumalai Chemicals Ltd, the other manufacturer of phthalic anhydride, has already shut down its plant.

Asian Paints is also nursing a huge inventory as cheap imports have chocked demand for the companies products, company sources said.

The unit is a part of Asian Paint's backward integration strategy and accounts for 2.7 per cent of the total revenue of the company.

The Ankleshwar plant produces PAN for Asian Paint's own use and also sell it to other paint manufacturers.

Asian Paints reported a 30 per cent rise in fiscal first-half  sales at Rs2,717 crore and a 21 per cent rise in profit at Rs237 crore.

Latest articles

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

AI startup Reflection signs over $1 billion computing deal with Nebius

AI startup Reflection signs over $1 billion computing deal with Nebius

Tata Power explores $450 million overseas loan for business operations

Tata Power explores $450 million overseas loan for business operations

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

South Korean firms unveil $195 billion investment in AI and advanced industries

South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs